Published Apr 2, 2024
Adapting Biopharma to AI with Greg Meyers
Greg Meyers, EVP and Chief Digital and Technology Officer at Bristol Myers Squibb, explores the revolutionary impact of AI on drug discovery, digital transformation, and strategic partnerships, emphasizing new research methodologies and effective collaborations within the pharmaceutical landscape.
Topics covered
Popular Clips
Episode Highlights
Related Episodes
Adapting Biopharma to AI with Greg Meyers
Answers 383 questionsAdapting Biopharma to AI: A 2024 Update with Greg Meyers
Answers 383 questions
AI in Pharmaceutical R&D with Kim Branson
Answers 383 questions
AI at the Intersection of Bio with Vijay Pande, Surya Ganguli, and Bowen Liu
Answers 383 questions
AI and Actionable Insights for Drug Development with Daphne Koller
Answers 383 questionsBiotech Revolution with Software Engineering Daily
Answers 383 questions
Behind the Buy: Payors and Providers on AI Adoption
Answers 383 questionsAI is Here. Now What?
Answers 383 questions
Supercharging Discovery with Evan Feinberg
Answers 383 questions
AI + a16z with Vijay Pande
Answers 383 questions
The Intersection of Biotech x High Tech with Vineeta Agarwala
Answers 383 questionsThe Power of Drug Discovery with Philip Tagari
Answers 383 questions
The Transformative Power of AI in Science with Pushmeet Kohli
Answers 383 questions
Drugging the Undruggable with Greg Verdine
Answers 383 questionsExpert AI as a Healthcare Superpower
Answers 383 questions